America’s global leadership in medical innovation is at risk as policymakers advance policies that weaken innovation and threaten our competitive edge.
America’s leadership in medicine research, development and manufacturing has given patients access to lifesaving breakthroughs—often years before people in other countries can get them. But that progress is not guaranteed. Today, policies moving through Washington threaten the very innovation that patients depend on:
For patients and families waiting for better options—people battling cancer, Alzheimer’s, rare diseases and chronic conditions—these policies aren’t abstract. They determine whether the next generation of treatments will arrive in time.
Patients are counting on our innovative ecosystem to keep delivering the cures they need.
To sustain American leadership and protect innovation, policymakers must advance smart policies that will deliver more affordable treatments and cures to Americans. To protect American’s innovation ecosystem, policymakers must:
